期刊文献+

不同部位胰腺癌的误诊分析 被引量:1

Analyses of Misdiagnose of Carcinomas Arising from Different part of Pancreas
下载PDF
导出
摘要 目的分析不同部位胰腺肿瘤的误诊情况,提高胰腺癌诊断率,降低误诊误治率。方法回顾性分析222例胰腺癌患者的误诊原因。结果 222例中50例患者被误诊,误诊率为22.5%。发病部位不同,其误诊情况也不同,其中胰头癌140例,误诊34例(24.3%),误诊为胃炎和胰腺炎。胰体癌16例,误诊9例(56.3%),误诊为腰椎间盘突出症和贲门失迟缓症。胰尾癌41例,误诊5例(12.2%),误诊为胃炎和腰椎间盘突出症。全胰癌24例,误诊2例(8.3%),均误诊为胰腺炎。结论胰腺癌早期临床症状不典型,极易发生误诊,且不同部位误诊率及误诊情况各有不同,应该重视胰腺癌的早期临床表现,避免误诊的发生。 Objective To Analyze the misdiagnoses of pancreatic carcinoma arising from different part of the pancreas.Methods The clinical data of 222 patients diagnosed with pancreatic cancer were ana1ized retrospective1y.Results 50 patients experienced misdiagnoses,and the misdiagnosis rate was 22.5%.Of the 140 patients with pancreatic head carcinoma,34 were misdiagnosed.The main misdiagnosed diseases were gastritis and pancreatitis.Of the 16 patients whose carcinoma was situated in the pancreatic body,9 were misdiagnosed,and the main misdiagnosed diseases were cardielcosis and lumbar disc protrusion.41 patients had pancreatic tile carcinoma,and 5 were misdiagnosed as gastritis or lumbar disc protrusion.The carcinoma infiltrated to the whole pancreas in 24 patients,in which 2 patients were misdiagnosed as acute pancreatitis.Conclusion Misdiagnoses of pancreatic carcinoma are common due to their untypical symptoms in the early stage.The misdiagnosis rate is related to the part of the pancreas from which it arises.Doctors should pay attention to the clinical symptoms,and avoid misdiagnose.
出处 《实用癌症杂志》 2012年第2期153-154,170,共3页 The Practical Journal of Cancer
基金 国家自然科学基金资助项目(81071982) 辽宁省博士科研启动基金项目(20111094)
关键词 胰腺肿瘤 误诊 Pancreatic carcinoma Misdiagnosis
  • 相关文献

参考文献3

二级参考文献21

  • 1Jalanko H, Kuusela P, Roberts P,et al. Comparision of a new tumor marker, CA19-9, with alpha-fetoprotein and carcinoem bryonic antigen in patients with upper gastrointestinal diseases [J]. J Clin Pathol, 1984,37(2) :218-222.
  • 2Cappelli G,Paladini S,Agata A,et al. Tumor markers in the diagnosis of pancreatic cancer[J]. Tumori, 1999,85 ( 1 ) : 19-21.
  • 3Grzegorz C, Grzegorz W, Tomasz S, et al. Cancer antigens 199 and 125 in the differential diagnosis of pancreatic mass lesions [J]. Arch Surg,2006,141 (9) :968-973.
  • 4Ni XG, Bai XF, Mao YL, et al. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer [J]. Euro J Surg Oncol, 2005, 31 (2): 164 -169.
  • 5Nelson MO, DeL and FH, Shocat D, et al. External imaging of gastric cancer metastases with radiolabelled CEA and CSAp antibodies[J]. N Engl J Med, 1983,308(14):847.
  • 6Li D,Xie K,Wolff R,et al.Pancreatic cancer[J].Lancet,2004,363 (9414):1049.
  • 7Goldstein D,Garroll S,Apte M,et al.Modern management of pancreatic carcinoma[J].Intern Med J,2004,34 (8):475.
  • 8Sobin LH,Wittekind C.UICC-TNM classification of malignant tumours[M].6th ed.New York:Wiley-Lissm,2002.
  • 9Simon B,Printz H.Epidemiological trends in pancreatic neoplasias[J].Dig Dis,2001,19 (1):6.
  • 10Li D,Yeung S C,Hassan M M,et al.Antidiabetic therapies affect risk of pancreatic cancer[J].Gastroenterology,2009,137(2):482.

共引文献11

同被引文献2

  • 1姚宏昌,唐艳萍.胰源性消化道出血[J].中华消化杂志,2006,26(7):498-499. 被引量:6
  • 2Bao Y, Spiegelman D, Li R,et al. History of peptic ulcer disease and pancreatic cancer risk in men [ J ]. Gastroenterology,2010,138 (2) : 541-549.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部